Firms cash in on GSK JV with Novartis
Partners at Linklaters and Freshfields Bruckhaus Deringer are among the 500 lawyers to have cashed in on the billion-dollar joint venture between Novartis and GlaxoSmithKline (GSK), The Lawyer reported. The pharmaceutical giants will swap assets as...


































































































































